[1]Chu Qiaoqiao,Liu Tao,Jia Shouwei,et al.Serglycin stable interference with increased sensitivity to cisplatin in nasopharyngeal carcinoma with high metastatic cells [J].Chin J Pharmaceutical Sciences,2015,50(8):676-680.[储悄悄,刘韬,贾守薇,等.Serglycin稳定干扰增加鼻咽癌高转移细胞对顺铂的敏感性[J].中国药学杂志,2015,50(8):676-680.]
[2]Kwok H,Wu CW,Palser AL,et al.Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples[J].J Virology,2014,88(18):10662-10672.
[3]Xu Zhiyuan.Study on the radiation sensitivity of human nasopharyngeal carcinoma cell line [D].Shantou:Shantou University,2007.[徐志渊.人鼻咽癌耐顺铂细胞系的放射敏感性研究[D].汕头:汕头大学,2007.]
[4]Gong Z,Qian Y,Zeng Z,et al.An integrative transcriptomic analysis reveals p53 regulated miRNA,mRNA,and lncRNA networks in nasopharyngeal carcinoma[J].Tumor Biology,2015,37(3):1-13.
[5]Jiang H,Gao M,Shen Z,et al.Blocking PI3K/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition[J].Oncology Reports,2014,32(2):559-566.
[6]Yi HM,Yi H,Zhu JF,et al.A five-variable signature predicts radioresistance and prognosis in nasopharyngeal carcinoma patients receiving radical radiotherapy[J].Tumor Biology,2015,37(3):1-9.
[7]Lee AW,Law SC,Ng SH,et al.Retrospective analysis of nasopharyngeal carcinoma treated during 1976-1985:Late complications following megavoltage irradiation[J].British J Radiology,2014,65(778):918-928.
[8]Chua MK,Wee JTS,Hui EP,et al.Nasopharyngeal carcinoma[J].Lancet,2015,7(3):388-393.
[9]Wu Fang.Multi center,open,randomized controlled study of advanced nasopharyngeal carcinoma treated with radiotherapy and chemotherapy[D].Nanning:Guangxi Medical University,2014.[吴芳.放化综合治疗局部晚期鼻咽癌的多中心、开放性、随机对照研究[D].南宁:广西医科大学,2014.]
[10]Li Dan.Experimental study on the effect of continuous chemotherapy with small dose of cisplatin on CNE-1 cell kinetics and radiation sensitivity of nasopharyngeal carcinoma [D].Suzhou:Soochow University,2009.[李丹.小剂量顺铂连续化疗对鼻咽癌CNE-1细胞动力学以及放射敏感性影响的实验研究[D].苏州:苏州大学,2009.]
[11]Li XJ,Ong CK,Cao Y,et al.Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis[J].Cancer Res,2011,71(8):3162-3172.
[12]Tsao SW,Yip YL,Chi MT,et al.Etiological factors of nasopharyngeal carcinoma[J].Oral Oncology,2014,50(5):330-338.
[13]Kolset SO,Pejler G.Serglycin:A structural and functional chame-leon with wide impact on immune cells[J].J Immunol,2011,187(10):4927-4933.